Regulatory innovation for health products: Agile licensing for drugs

Regulatory innovation for health products: Agile licensing for drugs The Canadian market now includes a much larger number of drugs that reflect a wider range of risks. Our drug regulatory system needs to be more agile to give people better access to the drugs they need. 2022-06-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyregulatory-innovation for health-productsadvanced therapeutic productsagile-licensing for drugsclinical-trialsregulatory innovationmodernizing clinical-trial regulations Regulatory innovation for health products: Agile licensing for drugsHTML https://www.canada.ca/en/health-canada/corporate/about-health-canada/activities-responsibilities/strategies-initiatives/health-products-food-regulatory-modernization/agile-licensing-drugs.html Regulatory innovation for health products: Agile licensing for drugsHTML https://www.canada.ca/fr/sante-canada/organisation/a-propos-sante-canada/activites-responsabilites/strategies-initiatives/modernisation-reglementation-aliments-produits-sante/licence-agile-medicaments.html

The Canadian market now includes a much larger number of drugs that reflect a wider range of risks. Our drug regulatory system needs to be more agile to give people better access to the drugs they need.

Data and Resources

Similar records